![Adelina Louie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adelina Louie
Direktor/Vorstandsmitglied bei
MAIA BIOTECHNOLOGY, INC.
Vermögen: 1 Mio $ am 30.09.2026
Profil
Ms. Adelina N.
Louie is an Independent Non-Executive Director at MAIA Biotechnology, Inc. She is on the Board of Directors at MAIA Biotechnology, Inc. Ms. Louie was previously employed as a Chief Compliance Officer by Nomura Partners Funds, Inc., a Chief Operating Officer by HSBC Investments (Taiwan) Ltd., and a Secretary & Treasurer by The Taiwan Fund, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC. 2,05 % | 30.06.2026 | 1.248.888 ( 2,05 % ) | 1 Mio $ | 30.09.2026 |
Aktive Positionen von Adelina Louie
| Unternehmen | Position | Beginn |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.04.2020 |
Ehemalige bekannte Positionen von Adelina Louie
| Unternehmen | Position | Ende |
|---|---|---|
| THE TAIWAN FUND, INC. | Unternehmenssekretär | 08.05.2010 |
HSBC Global Asset Management (Taiwan) Ltd.
 HSBC Global Asset Management (Taiwan) Ltd. Investment ManagersFinance HSBC-GAM Taiwan is a GARP-oriented manager which focuses on long-term capital appreciation. They emphasize fundamental research and invest primarily in equities listed on the Taiwan stock exchange, complemented with bonds and convertibles. They are self-described 'business cycle investor' following a combination of value- and growth-oriented investment approaches. They typically favor the technology sector, in particular industries such as telecommunications, electronics, semiconductors and personal computing. The firm combines top-down sector allocation and bottom-up security selection, seeking to invest in Taiwanese companies with growth potential, a competitive edge on export markets, strong technology, efficient R&D, quality management, a favorable regulatory environment and access to low-cost labor and raw materials. Key selection criteria include profit margins, return on investment and capital resources. Research is shared within HSBC. The group's Global Investment Strategy Group (GISG) defines monthly a macro investment strategy covering global economic projections, fixed-income expected returns, Forex projections, regional equity market performance expectations and global views on key sectors. Local specialist teams perform fundamental research including company visits. | Geschäftsführer | 01.04.2006 |
Nomura Partners Funds, Inc.
 Nomura Partners Funds, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Compliance Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Nomura Partners Funds, Inc.
Nomura Partners Funds, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Taiwan Fund, Inc. (The)
 Taiwan Fund, Inc. (The) Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
HSBC Global Asset Management (Taiwan) Ltd.
HSBC Global Asset Management (Taiwan) Ltd. Investment ManagersFinance HSBC-GAM Taiwan is a GARP-oriented manager which focuses on long-term capital appreciation. They emphasize fundamental research and invest primarily in equities listed on the Taiwan stock exchange, complemented with bonds and convertibles. They are self-described 'business cycle investor' following a combination of value- and growth-oriented investment approaches. They typically favor the technology sector, in particular industries such as telecommunications, electronics, semiconductors and personal computing. The firm combines top-down sector allocation and bottom-up security selection, seeking to invest in Taiwanese companies with growth potential, a competitive edge on export markets, strong technology, efficient R&D, quality management, a favorable regulatory environment and access to low-cost labor and raw materials. Key selection criteria include profit margins, return on investment and capital resources. Research is shared within HSBC. The group's Global Investment Strategy Group (GISG) defines monthly a macro investment strategy covering global economic projections, fixed-income expected returns, Forex projections, regional equity market performance expectations and global views on key sectors. Local specialist teams perform fundamental research including company visits. | Finance |
MAIA Biotechnology, Inc.
 MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
